The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin
Abstract
OBJECTIVE: To determine if continuous intrathecal baclofen infusion (CIBI) would provide continuous relief of spasticity in patients with spasticity of cerebral origin, especially children with cerebral palsy. DESIGN: Prospective, unblinded trial, before and after CIBI. SETTING: Children's Hospital of Pittsburgh (Pa). PATIENTS: Thirty-seven patients, 5 to 27 years of age, with spasticity of cerebral origin. INTERVENTION: Continuous intrathecal baclofen infusion for 3 to 48 months. MAIN OUTCOME MEASURES: Muscle tone, range of motion, upper extremity timed tasks, activities of daily living (ADLs). RESULTS: Six and 12 months after CIBI, muscle tone was significantly decreased in the upper (P = .04) and lower (P = .001) extremities. There was a significant relationship between baclofen dosage and muscle tone in the upper (P = .02) and lower (P = .001) extremities. Hamstring motion, upper extremity function, and ADLs were significantly improved in 25 patients who were capable of self-care. CONCLUSION: Spasticity of cerebral origin can be effectively treated with CIBI. Because baclofen dosages can be titrated for the desired clinical response, CIBI is particularly useful for patients who need some spasticity to stand and ambulate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
Ashworth, B. (1964) · PubMed · Cited by 1,475
Intrathecal Baclofen for Severe Spinal Spasticity
Penn, R. D., Savoy, S. M., Corcos, D., Latash, M., Gottlieb, G., Parke, B., & Kroin, J. S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202303 · Cited by 754
Antispasticity drugs: Mechanisms of action
Davidoff, R. A. (1985) · Annals of Neurology · doi:10.1002/ana.410170202 · Cited by 340
Intrathecal Baclofen for Spasticity in Cerebral Palsy
Albright, A. L. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110084029 · Cited by 293
Self-citationIntrathecal baclofen for spasticity of spinal origin: seven years of experience
Penn, R. D. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0236 · Cited by 279
Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.
Ochs, G., Struppler, A., Meyerson, B. A., Linderoth, B., Gybels, J., Gardner, B. P., Teddy, P., Jamous, A., & Weinmann, P. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.8.933 · Cited by 168
Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury
Loubser, P. G., Narayan, R. K., Sandin, K. J., Donovan, W. H., & Russell, K. D. (1991) · Spinal Cord · doi:10.1038/sc.1991.7 · Cited by 146
INTRATHECAL BACLOFEN FOR SPASTICITY
Dralle, D., Müller, H., Zierski, J., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90541-0 · Cited by 103
Surgical Management of Spastic Diplegia in Cerebral Palsy
Desforges, J. F., Park, T. S., & Owen, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203123261106 · Cited by 67
Cited by
Management of upper limb dysfunction in children with cerebral palsy: a systematic review
Boyd, R. N., Morris, M. E., & Graham, H. K. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00048.x · Cited by 267
Scholtes, V. A. B., Becher, J. G., Beelen, A., & Lankhorst, G. J. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206000132 · Cited by 253
Drugs Used to Treat Spasticity
Kita, M., & Goodkin, D. E. (2000) · Drugs · doi:10.2165/00003495-200059030-00006 · Cited by 172
Metadata
- Authors
- Albright, A. L.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1993-11-24
- Volume
- 270
- Issue
- 20
- Pages
- 2475
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2131292270
- Cited by
- 303
- References
- 9
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin. https://app.cochat.ai/papers/10.1001/jama.1993.03510200081036
- The paper
- Albright, A. L. (1993). Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1993.03510200081036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.